jueves, 27 de marzo de 2025

Overcoming delivery hurdles, IL-12 tackles ovarian cancer A targeted interleukin-12 gene therapy plus chemotherapy increased survival in advanced ovarian cancer, setting the stage for a new first-line drug.

https://www.drugdiscoverynews.com/overcoming-delivery-hurdles-il-12-tackles-ovarian-cancer-16283?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-88LqTuiJ3sAh68iF3XqovoMS9NEFyM8LhDUvfpExh1ygOn2n0vP93krwlqbm1STvTzsgxNFsP0ZlSOJsJVzgr4cP7zDA&_hsmi=353912764&utm_content=353912764&utm_source=hs_email

No hay comentarios:

Publicar un comentario